Prolactin and estrogen receptors in breast cancer.
D000616:Aminoglutethimide / Q000627:therapeutic use; D000818:Animals; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D003907:Dexamethasone / Q000627:therapeutic use; D004195:Disease Models, Animal; D004965:Estrogen Antagonists / Q000494:pharmacology; D004967:Estrogens / Q000378:metabolism*; D005260:Female; D006801:Humans; D008325:Mammary Neoplasms, Experimental / Q000378:metabolism / Q000503:physiopathology*; D011388:Prolactin / Q000502:physiology*; D051381:Rats; D011956:Receptors, Cell Surface / Q000502:physiology*; D011960:Receptors, Estrogen / Q000378:metabolism*
D004965:Estrogen Antagonists; D004967:Estrogens; D011956:Receptors, Cell Surface; D011960:Receptors, Estrogen; D000616:Aminoglutethimide; D003907:Dexamethasone; D011388:Prolactin